U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 1-7, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 1-7, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 09/05/2024
Location: Virtual
Subject: National Advisory Child Health and Human Development Council
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other registered participants

Event Date: 09/06/2024
Location: Virtual
Subject: Stimulant Medication Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of several professional associations

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 09/03/2024
Location: Virtual
Subject: Food Safety and Tobacco Issues of Mutual Interest
FDA Participant/Group: BRIAN KING;
Non FDA Participant/Group: Representative Anna Eshoo (D-CA)

Event Date: 09/06/2024
Location: Virtual
Subject: Infant Formula
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Claire Wengrod (Senate Appropriations Committee, Subcommittee on Agriculture, Rural Development, and the Food and Drug Administration); Shauna Rust, Tara Hartnett (Senator Patty Murray's (D-WA) Office);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 09/04/2024
Location: Virtual
Subject: International Work
FDA Participant/Group: RAVI BHARWANI
Non FDA Participant/Group: Barbara Bierer (Harvard Multi-Regional Trial Center);

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 09/05/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Anabela Marcal, Emer Cooke (European Medicines Agency (EMA));

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/04/2024
Location: Virtual
Subject: Global Bio Conference 2024 Grand Transitions in Bio: Designing the Next Decade (Korea); Facilitating the Development of the Next Wave of Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, research, and international regulatory stakeholders

Event Date: 09/04/2024
Location: Virtual
Subject: Society for the Study of Inborn Errors of Metabolism/Citrin Foundation Roundtable: Multi-stakeholder Perspectives on the Development of Novel Therapies for Monogenic Metabolic Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Regulators, clinicians, researchers, and patient advocacy stakeholders

Event Date: 09/04/2024
Location: Washington, DC
Subject: Reagan-Udall Foundation Public Workshop - Scientific Advancements in Gene Therapies; Panelist: Opportunities for Global Regulatory Convergence
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and patient advocate stakeholders

Event Date: 09/04/2024
Location: National Harbor, MD
Subject: Defense Strategies Institute - Government Biotechnology Innovation Summit: Advancing Safe and Effective Biologics: The Role of Regulatory Science in Public Health
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and government stakeholders

Event Date: 09/06/2024
Location: Virtual
Subject: Global Bio Conference 2024-Grand Transitions in Bio: Designing the Next Decade (Korea): Advancing the Development of Cancer Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, research, and international regulatory stakeholders

Event Date: 09/07/2024
Location: Miami, FL
Subject: Cord Blood Connect 2024: Regulatory and Ethical Aspects of Cord Blood and Birthing Tissues as Starting Materials for Manufacture of Cellular and Regenerative Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, and research stakeholders

Event Date: 09/07/2024
Location: Miami, FL
Subject: Cord Blood Connect 2024: Meet the Expert: Regulatory Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, and research stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Acting Director, Center for Devices and Radiological Health

Event Date: 09/05/2024
Location: Silver Spring, MD
Subject: CDRH Patient Engagement Town Hall; Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members of industry, government, patients and patient groups, academia, and other stakeholders

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 09/04/2024
Location: Brussels, Belgium
Subject: Issues of Mutual Interest
FDA Participant/Group: FAZILA SHAKIR; KATHERINE SERRANO; ALESSANDRO FIORELLI;
Non FDA Participant/Group: Claire Bury, Koen Van Dyck (European Commission (EC) Health and Food Safety (DG-SANTE));

Event Date: 09/04/2024
Location: Brussels, Belgium
Subject: European Food Forum Meeting
FDA Participant/Group: ALESSANDRO FIORELLI; FAZILA SHAKIR; KATHERINE SERRANO;
Non FDA Participant/Group: Representatives from industry, research, academia, policymakers, and other stakeholders

Event Date: 09/05/2024
Location: Virtual
Subject: Celebrating CODEX Alimentarius
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry, research, academia, policymakers, and other stakeholders

Event Date: 09/05/2024
Location: Barcelona, Spain
Subject: 14th Global Microbial Identifier Conference; Speaker: U.S. and E.U. Challenges and Opportunities of Whole Genome Sequencing (WGS)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry, research, academia, policymakers, and other stakeholders

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top